Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 474

1.

Premature mortality of people with personality disorder in the Nottingham Study of Neurotic Disorder.

Tyrer P, Tyrer H, Yang M.

Personal Ment Health. 2019 Aug 15. doi: 10.1002/pmh.1466. [Epub ahead of print]

PMID:
31414571
2.

Increase in the prevalence of health anxiety in medical clinics: Possible cyberchondria.

Tyrer P, Cooper S, Tyrer H, Wang D, Bassett P.

Int J Soc Psychiatry. 2019 Nov;65(7-8):566-569. doi: 10.1177/0020764019866231. Epub 2019 Aug 3.

3.

Why we need to take personality disorder out of the doghouse.

Tyrer P.

Br J Psychiatry. 2019 May 31:1-2. doi: 10.1192/bjp.2019.125. [Epub ahead of print]

PMID:
31148538
4.

Enhanced peer-review for optimising publication of biomedical papers submitted from low- and middle-income countries: feasibility study for a randomised controlled trial - CORRIGENDUM.

Pitman A, Underwood R, Hamilton A, Tyrer P, Yang M.

BJPsych Open. 2019 Mar;5(2):e28. doi: 10.1192/bjo.2019.17. No abstract available.

5.
6.

Nidotherapy: a cost-effective systematic environmental intervention.

Tyrer P.

World Psychiatry. 2019 Jun;18(2):144-145. doi: 10.1002/wps.20622. No abstract available.

7.

Health anxiety.

Hedman-Lagerlöf E, Tyrer P, Hague J, Tyrer H.

BMJ. 2019 Mar 12;364:l774. doi: 10.1136/bmj.l774. No abstract available.

PMID:
30862624
8.

An RCT of brief cognitive therapy versus treatment as usual in patients with non-cardiac chest pain.

Mulder R, Zarifeh J, Boden J, Lacey C, Tyrer P, Tyrer H, Than M, Troughton R.

Int J Cardiol. 2019 Aug 15;289:6-11. doi: 10.1016/j.ijcard.2019.01.067. Epub 2019 Feb 5.

PMID:
30770262
9.

The Development of the ICD-11 Classification of Personality Disorders: An Amalgam of Science, Pragmatism, and Politics.

Tyrer P, Mulder R, Kim YR, Crawford MJ.

Annu Rev Clin Psychol. 2019 May 7;15:481-502. doi: 10.1146/annurev-clinpsy-050718-095736. Epub 2019 Jan 2.

PMID:
30601688
10.

Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders.

Reed GM, First MB, Kogan CS, Hyman SE, Gureje O, Gaebel W, Maj M, Stein DJ, Maercker A, Tyrer P, Claudino A, Garralda E, Salvador-Carulla L, Ray R, Saunders JB, Dua T, Poznyak V, Medina-Mora ME, Pike KM, Ayuso-Mateos JL, Kanba S, Keeley JW, Khoury B, Krasnov VN, Kulygina M, Lovell AM, de Jesus Mari J, Maruta T, Matsumoto C, Rebello TJ, Roberts MC, Robles R, Sharan P, Zhao M, Jablensky A, Udomratn P, Rahimi-Movaghar A, Rydelius PA, Bährer-Kohler S, Watts AD, Saxena S.

World Psychiatry. 2019 Feb;18(1):3-19. doi: 10.1002/wps.20611.

11.

Diagnosis and classification of personality disorders: novel approaches.

Mulder R, Tyrer P.

Curr Opin Psychiatry. 2019 Jan;32(1):27-31. doi: 10.1097/YCO.0000000000000461.

PMID:
30234525
12.

Reforming care without bureaucracy.

Tyrer P.

BJPsych Bull. 2019 Jun;43(3):104-105. doi: 10.1192/bjb.2018.69. Epub 2018 Sep 12.

13.

Dimensions fit the data, but can clinicians fit the dimensions?

Tyrer P.

World Psychiatry. 2018 Oct;17(3):295-296. doi: 10.1002/wps.20559. No abstract available.

14.

Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody-Drug Conjugate Targeting PSMA, in Preclinical Models of Prostate Cancer.

Cho S, Zammarchi F, Williams DG, Havenith CEG, Monks NR, Tyrer P, D'Hooge F, Fleming R, Vashisht K, Dimasi N, Bertelli F, Corbett S, Adams L, Reinert HW, Dissanayake S, Britten CE, King W, Dacosta K, Tammali R, Schifferli K, Strout P, Korade M 3rd, Masson Hinrichs MJ, Chivers S, Corey E, Liu H, Kim S, Bander NH, Howard PW, Hartley JA, Coats S, Tice DA, Herbst R, van Berkel PH.

Mol Cancer Ther. 2018 Oct;17(10):2176-2186. doi: 10.1158/1535-7163.MCT-17-0982. Epub 2018 Jul 31.

15.

Accurate recording of personality disorder in clinical practice.

Tyrer P.

BJPsych Bull. 2018 Aug;42(4):135-136. doi: 10.1192/bjb.2018.40.

16.

Recent Advances in the Understanding and Treatment of Health Anxiety.

Tyrer P.

Curr Psychiatry Rep. 2018 Jun 22;20(7):49. doi: 10.1007/s11920-018-0912-0. Review.

PMID:
29931576
17.

Dissecting the elements of borderline personality disorder.

Tyrer P, Mulder R.

Personal Ment Health. 2018 May;12(2):91-92. doi: 10.1002/pmh.1422. No abstract available.

PMID:
29878704
18.

The Importance of Nidotherapy and Environmental Change in the Management of People with Complex Mental Disorders.

Tyrer P.

Int J Environ Res Public Health. 2018 May 13;15(5). pii: E972. doi: 10.3390/ijerph15050972.

19.

Robert Spitzer's legacy: agreement is halfway to truth.

Tyrer P.

BJPsych Bull. 2018 Oct;42(5):198-199. doi: 10.1192/bjb.2018.22. Epub 2018 May 7.

20.

Lamotrigine for people with borderline personality disorder: a RCT.

Crawford MJ, Sanatinia R, Barrett B, Cunningham G, Dale O, Ganguli P, Lawrence-Smith G, Leeson VC, Lemonsky F, Lykomitrou-Matthews G, Montgomery A, Morriss R, Munjiza J, Paton C, Skorodzien I, Singh V, Tan W, Tyrer P, Reilly JG.

Health Technol Assess. 2018 Apr;22(17):1-68. doi: 10.3310/hta22170.

21.

The Clinical Effectiveness and Cost-Effectiveness of Lamotrigine in Borderline Personality Disorder: A Randomized Placebo-Controlled Trial.

Crawford MJ, Sanatinia R, Barrett B, Cunningham G, Dale O, Ganguli P, Lawrence-Smith G, Leeson V, Lemonsky F, Lykomitrou G, Montgomery AA, Morriss R, Munjiza J, Paton C, Skorodzien I, Singh V, Tan W, Tyrer P, Reilly JG; LABILE study team.

Am J Psychiatry. 2018 Aug 1;175(8):756-764. doi: 10.1176/appi.ajp.2018.17091006. Epub 2018 Apr 6.

22.

Against the Stream: Generalised anxiety disorder (GAD) - a redundant diagnosis.

Tyrer P.

BJPsych Bull. 2018 Apr;42(2):69-71. doi: 10.1192/bjb.2017.12. Epub 2018 Mar 1.

23.

ADCT-402, a PBD dimer-containing antibody drug conjugate targeting CD19-expressing malignancies.

Zammarchi F, Corbett S, Adams L, Tyrer PC, Kiakos K, Janghra N, Marafioti T, Britten CE, Havenith CEG, Chivers S, D'Hooge F, Williams DG, Tiberghien A, Howard PW, Hartley JA, van Berkel PH.

Blood. 2018 Mar 8;131(10):1094-1105. doi: 10.1182/blood-2017-10-813493. Epub 2018 Jan 3.

PMID:
29298756
24.

Borderline hits the diagnostic buffers again.

Tyrer P.

Bipolar Disord. 2017 Nov;19(7):599-600. doi: 10.1111/bdi.12568. No abstract available.

PMID:
29205720
25.

Cognitive-behaviour therapy for health anxiety in medical patients (CHAMP): a randomised controlled trial with outcomes to 5 years.

Tyrer P, Salkovskis P, Tyrer H, Wang D, Crawford MJ, Dupont S, Cooper S, Green J, Murphy D, Smith G, Bhogal S, Nourmand S, Lazarevic V, Loebenberg G, Evered R, Kings S, McNulty A, Lisseman-Stones Y, McAllister S, Kramo K, Nagar J, Reid S, Sanatinia R, Whittamore K, Walker G, Philip A, Warwick H, Byford S, Barrett B.

Health Technol Assess. 2017 Sep;21(50):1-58. doi: 10.3310/hta21500.

26.

Personality disorder: Good reasons to reclassify.

Tyrer P.

Aust N Z J Psychiatry. 2017 Nov;51(11):1077-1078. doi: 10.1177/0004867417728808. Epub 2017 Sep 6. No abstract available.

PMID:
28875727
28.

Nidotherapy in the successful management of comorbid depressive and personality disorder.

Spears B, Tyrer H, Tyrer P.

Personal Ment Health. 2017 Nov;11(4):344-350. doi: 10.1002/pmh.1370. Epub 2017 Jul 17.

PMID:
28714268
29.

A prospective, quantitative study of mental health act assessments in England following the 2007 amendments to the 1983 act: did the changes fulfill their promise?

Singh SP, Paul M, Parsons H, Burns T, Tyrer P, Fazel S, Deb S, Islam Z, Rugkåsa J, Gajwani R, Thana L, Crawford MJ.

BMC Psychiatry. 2017 Jul 10;17(1):246. doi: 10.1186/s12888-017-1391-2.

30.

Clinical and cost-effectiveness of adapted cognitive behaviour therapy for non-cardiac chest pain: a multicentre, randomised controlled trial.

Tyrer P, Tyrer H, Morriss R, Crawford M, Cooper S, Yang M, Guo B, Mulder RT, Kemp S, Barrett B.

Open Heart. 2017 May 16;4(1):e000582. doi: 10.1136/openhrt-2016-000582. eCollection 2017.

31.

A response to 'validating the proposed ICD-11 domains'.

Mulder R, Tyrer P, Horwood J.

Personal Ment Health. 2017 Nov;11(4):213-214. doi: 10.1002/pmh.1374. Epub 2017 May 22. No abstract available.

PMID:
28544555
32.

Development and Psychometric Properties of the Standardized Assessment of Severity of Personality Disorder (SASPD).

Olajide K, Munjiza J, Moran P, O'Connell L, Newton-Howes G, Bassett P, Akintomide G, Ng N, Tyrer P, Mulder R, Crawford MJ.

J Pers Disord. 2018 Feb;32(1):44-56. doi: 10.1521/pedi_2017_31_285. Epub 2017 May 17. Erratum in: J Pers Disord. 2017 Oct;31(5):720.

33.

Antipathy towards people with personality disorders.

Tyrer P.

BJPsych Bull. 2017 Apr;41(2):122. doi: 10.1192/pb.41.2.122. No abstract available.

34.

Articulation and testing of a personality-centred model of psychopathology: evidence from a longitudinal community study over 30 years.

Hengartner MP, Tyrer P, Ajdacic-Gross V, Angst J, Rössler W.

Eur Arch Psychiatry Clin Neurosci. 2018 Aug;268(5):443-454. doi: 10.1007/s00406-017-0796-8. Epub 2017 Apr 7.

PMID:
28389890
35.

Exploring professionals' understanding, interpretation and implementation of the 'appropriate medical treatment test' in the 2007 amendment of the Mental Health Act 1983.

Perry BI, Champaneri N, Griffiths F, Paul M, Islam Z, Rugkåsa J, Burns T, Tyrer P, Crawford M, Deb S, Singh SP.

BJPsych Open. 2017 Feb 23;3(1):57-63. doi: 10.1192/bjpo.bp.116.003939. eCollection 2017 Jan.

36.

Psychiatric hospital beds: an Orwellian crisis.

Tyrer P, Sharfstein S, O'Reilly R, Allison S, Bastiampillai T.

Lancet. 2017 Jan 28;389(10067):363. doi: 10.1016/S0140-6736(17)30149-6. No abstract available.

PMID:
28137687
37.

Nidotherapy compared with enhanced care programme approach training for adults with aggressive challenging behaviour and intellectual disability (NIDABID): cluster-randomised controlled trial.

Tyrer P, Tarabi SA, Bassett P, Liedtka N, Hall R, Nagar J, Imrie A, Tyrer H.

J Intellect Disabil Res. 2017 Jun;61(6):521-531. doi: 10.1111/jir.12360. Epub 2017 Jan 26.

PMID:
28124397
38.

Dependence: a strange but important outlier in personality disorders.

Tyrer P.

Personal Ment Health. 2016 Nov;10(4):323-324. doi: 10.1002/pmh.1358. Epub 2016 Sep 28. No abstract available.

PMID:
27678222
39.

ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies.

Flynn MJ, Zammarchi F, Tyrer PC, Akarca AU, Janghra N, Britten CE, Havenith CE, Levy JN, Tiberghien A, Masterson LA, Barry C, D'Hooge F, Marafioti T, Parren PW, Williams DG, Howard PW, van Berkel PH, Hartley JA.

Mol Cancer Ther. 2016 Nov;15(11):2709-2721. Epub 2016 Aug 17.

40.

The Problem Behaviour Checklist: short scale to assess challenging behaviours.

Tyrer P, Nagar J, Evans R, Oliver P, Bassett P, Liedtka N, Tarabi A.

BJPsych Open. 2016 Feb 5;2(1):45-49. eCollection 2016 Jan.

41.

Impact of personality status on the outcomes and cost of cognitive-behavioural therapy for health anxiety.

Sanatinia R, Wang D, Tyrer P, Tyrer H, Crawford M, Cooper S, Loebenberg G, Barrett B.

Br J Psychiatry. 2016 Sep;209(3):244-50. doi: 10.1192/bjp.bp.115.173526. Epub 2016 Jul 21.

42.

The General Neurotic Syndrome: A Re-Evaluation.

Tyrer P, Tyrer H, Guo B.

Psychother Psychosom. 2016;85(4):193-7. doi: 10.1159/000444196. Epub 2016 May 27. No abstract available.

43.

Schedule for personality assessment from notes and documents (SPAN-DOC): Preliminary validation, links to the ICD-11 classification of personality disorder, and use in eating disorders.

Kim YR, Tyrer P, Lee HS, Kim SG, Connan F, Kinnaird E, Olajide K, Crawford M.

Personal Ment Health. 2016 May;10(2):106-17. doi: 10.1002/pmh.1335.

44.

Dimensions of dependence and their influence on the outcome of cognitive behaviour therapy for health anxiety: randomized controlled trial.

Tyrer P, Wang D, Tyrer H, Crawford M, Cooper S.

Personal Ment Health. 2016 May;10(2):96-105. doi: 10.1002/pmh.1339.

45.

Validating the proposed ICD-11 domains.

Mulder RT, Horwood J, Tyrer P, Carter J, Joyce PR.

Personal Ment Health. 2016 May;10(2):84-95. doi: 10.1002/pmh.1336.

PMID:
27120419
46.

Health anxiety: the silent, disabling epidemic.

Tyrer P, Eilenberg T, Fink P, Hedman E, Tyrer H.

BMJ. 2016 Apr 25;353:i2250. doi: 10.1136/bmj.i2250. No abstract available.

PMID:
27112356
47.

Likelihood and predictors of detention in patients with personality disorder compared with other mental disorders: A retrospective, quantitative study of Mental Health Act assessments.

Olajide K, Tyrer P, Singh SP, Burns T, Rugkåsa J, Thana L, Paul M, Islam Z, Crawford MJ.

Personal Ment Health. 2016 Aug;10(3):191-204. doi: 10.1002/pmh.1332. Epub 2016 Mar 16.

48.

Long-term impact of temporary and persistent personality disorder on anxiety and depressive disorders.

Tyrer P, Tyrer H, Yang M, Guo B.

Personal Ment Health. 2016 May;10(2):76-83. doi: 10.1002/pmh.1324. Epub 2016 Jan 11.

PMID:
26754031
49.

Cognitive behaviour therapy for non-cardiac pain in the chest (COPIC): a multicentre randomized controlled trial with economic evaluation.

Tyrer P, Tyrer H, Cooper S, Barrett B, Kings S, Lazarevic V, Bransby-Adams K, Whittamore K, Walker G, McNulty A, Donaldson E, Midgley L, McCoy S, Evered R, Yang M, Guo B, Lisseman-Stones Y, Doukani A, Mulder R, Morriss R, Crawford M.

BMC Psychol. 2015 Nov 24;3:41. doi: 10.1186/s40359-015-0099-7.

50.

Preliminary field trial of a putative research algorithm for diagnosing ICD-11 personality disorders in psychiatric patients: 2. Proposed trait domains.

Kim YR, Tyrer P, Lee HS, Kim SG, Hwang ST, Lee GY, Mulder R.

Personal Ment Health. 2015 Nov;9(4):298-307. doi: 10.1002/pmh.1305. Epub 2015 Sep 7.

PMID:
26472077

Supplemental Content

Support Center